Menarini Silicon Biosystems launches the MSBiosuite Bioinformatic Platform
Cloud-based solution automates NGS data analysis for liquid biopsy and FFPE workflows
Cloud-based solution automates NGS data analysis for liquid biopsy and FFPE workflows
As we celebrate the first regulatory approval of a gene-editing based therapeutic, Casgevy™, for the treatment of sickle cell disease and transfusion-dependent β-thalassemia, we consider the gene-editing challenges that must be overcome before CRISPR gene-editing technology becomes a common treatment modality
Solutions to complement Company’s growing position in cell and gene therapy research and development
The research brings a deeper understanding about how fructose could be linked to diabetes and obesity
Join us on Monday, October 19, to find out how targeting BCMA and GPRC5D simultaneously could help to prevent tumor cell escape
Join us on Wednesday, July 29, to learn about the development of a metabolite profiling methodology that enables the accurate tracking of dietary behavior
Join this expert webinar to discover the complexities and challenges for wide patient access to new chimeric antigen receptor T (CAR-T) cell therapies
As a provider of advanced cell and particle instrumentation for the life science market, the funding aims to accelerate its research
Scientists aim to gain new insights into natural cell activity, accelerating drug development
The partners will host a joint conference on ‘Protein Sciences in Drug Discovery’ in Cambridge, UK, from November 18–19, 2024
Watch world-leading scientists and industry experts present the latest advances and emerging trends in biopharma, online December 8-10